Radiotherapy combined with other treatments in rectal cancer

Tumori

Volumn 84, Issue 2, 1998, Pages 238-246

  Valentini, Vincenzo ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b Istituto di Radiologia di Universita Cattolica del Sacro Cuore di Roma   (Italy)

Author keywords

Combined modality treatment; Radiotherapy; Rectal cancer

Indexed keywords

CISPLATIN; FOLINIC ACID; LEVAMISOLE;

BLOOD TOXICITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOPENIA; PREOPERATIVE EVALUATION; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; REVIEW;

EID: 0031800845     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169808400223     Document Type: Review

References (62)

1. Arnaud J.P., Nordlinger B., Bosset J.F., Boes G.H., Sahmoud T., Schlag P.M., Pene F.: Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer. Br. J. Surg., 84: 352-357, 1997.
2. Arnott S.J.: The value of combined 5-fluorouracil and x-ray therapy in the palliation of locally recurrent and inoperable rectal carcinoma. Clin. Radiol., 26: 177-182, 1975.
3. Bentzen S.M., Balslev I., Pedersen M., Teglbjaerg P.S., Hanberg Sorensen F., Bone J., Jacobsen N.O., Sell A., Overgaard J., Bertelsen K.: Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. Br. J. Cancer, 65: 102-107, 1992.
4. Bosset J.F., Horiot J.C.: Adjuvant treatment in the curative management of rectal cancer: a critical review of the results of clinical randomised trials. Eur. J. Cancer, 29A: 770-774, 1993.
5. Bosset J.F., Pavy J.J., Hamers H.P., Horiot J.C., Fabri M.C., Rougier P., Eschwege F., Schraub S.: Determination of the optimal dose of 5-fluorouracil when combined with low dose D,L-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. EORTC Radiotherapy Group. Eur. J. Cancer, 29A: 1406-1410, 1993.
6. Boulis Wassif S., Gerard A., Loygue J., Camelot D., Buyse M., Duez N.: Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Cancer, 53: 1811-1818, 1984.
7. Byfield J.E.: Theoretical basis and clinical applications of 5-Fluorouracil as a radiosensitizer - an overview. In: Concomitant Continous Infusion Chemotherapy and Radiation, Rotman M., Rosenthal C.J. (eds.), pp. 115-127, Springer Verlag, Berlin, 1991.
8. Cedermark B., Johansson H., Rutqvist L.E., Wilking N.: The stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. Cancer, 75: 2269-2275, 1995.
9. Cellini N., Valentini V., De Santis M., Morganti A.G., Trodella L., Coco C., Picciocchi A., Dobelbower R.R.Jr.: Radiosurgical treatment compared to surgery alone for rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 19: 1159-1164, 1990.
10. Chari R.S., Tyler D.S., Anscher M.S., Russell L., Clary B.M., Hathorn J., Seigler H.F.: Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann. Surg., 221:778-786, 1995.
11. Coia L.R., Hanks G.E.: The role of adjuvant radiation in the treatment of rectal cancer. Semin. Oncol., 18: 571-584, 1991.
12. Dahl O., Horn A., Morild I.: Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway. Cancer, 66: 2286-2294, 1990.
13. De Vita V.T., Lippman M., Hubbard S.M., Ihde D.C., Rosemberg S.A.: The effect of combined modality therapy on local control and survival. Int. J. Radiat. Oncol. Biol. Phys., 12: 487-501, 1986.
14. Decarli A., La Vecchia C.: Cancer mortality in Italy, 1993. Tumori, 83:643-649, 1997.
15. Dukes C.E.: The Classification of Cancer of the Rectum. J. Pathol., 35: 323-332, 1932.
16. Duncan W.: The evaluation of low dose pre-operative X-ray therapy in the management of operable rectal cancer, result of a randomly controlled trial. Br. J. Surg., 71: 21-24, 1984.
17. Fisher B., Wolmark N., Rockette H., Redmond C., Deutsch M., Wickerham D.L., Fisher E.R., Caplan R., Jones J., Lerner H.: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J. Natl. Cancer Inst., 80: 21-29, 1988.
18. Gerard A., Buyse M., Nordlinger B.: Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann. Surg., 208: 606-614, 1988.
19. GITSG 7175: Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N. Engl. J. Med., 312: 1465-1472, 1985.
20. GITSG 7180: Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group. J. Clin. Oncol., 10: 549-557, 1992.
21. Glimelius B., Isacsson U., Jung B., Pahlman L.: Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favoring preoperative treatment. Int. J. Radiat. Oncol. Biol. Phys., 37: 281-287, 1997.
22. Goldberg P.A., Nicholls R.J., Porter N.H., Love S., Grimsey J.E.: Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer reduction in local treatment failure. Eur. J. Cancer, 30A: 1602-1606, 1994.
23. Grann A., Minsky B.D., Cohen A.M., Saltz L., Guillen J.G., Paty P.B., Kelsen D.P., Kemeny N., Ilson D., Bass-Loeb J.: Preliminary results of preoperative 5-Fluorouracil, low-dose Leucovorin anc concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis. Colon Rectum, 40: 515-522, 1997.
24. Gunderson L.L., Sosin H.: Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer, 34: 1278-1292, 1974.
25. Heald R.J., Karanjia N.D.: Results of radical surgery for rectal cancer. World. J. Surg., 16: 848-857, 1992.
26. Higgins G.A., Humphrey E.W., Dwight R.W., Roswit B., Lee L.E.Jr., Keehn RJ.: Preoperative radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Group Trial II. Cancer, 58: 352-359, 1986.
27. Higgins G.A.Jr., Conn J.H., Jordan P.H.Jr., Humphrey E.W., Roswit B., Keehn R.J.: Preoperative radiotherapy for colorectal cancer. Ann. Surg., 181: 624-631, 1975.
28. Krook J.E., Moertel C.G., Gunderson L.L., Wieand H.S., Collins R.T., Beart R.W., Kubista T.P., Poon M.A., Meyers W.C., Mailliard J.A.: Effective surgical adjuvant therapy for high-risk rectal carcinoma [see comments]. N. Engl. J. Med., 324:709-715, 1991.
29. Marano P., Barbara B., De Franco A., Vecchioli A., Cellini N., Valentini V., Coco C., Doglietto G.B., Vecchio F.M.: Diagnostic and Therapeutic integration in rectal cancer. Preliminary notes. Radiol. Med., Torino, 84: 261-273, 1992.
30. Marsh P.J., James R.D., Schofield P.F.: Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective, randomized trial. Dis. Colon Rectum, 37: 1205-1214, 1994.
31. Minsky B., Cohen A., Enker W., Kelsen D., Kemeny N., Ilson D., Guillem J., Saltz L., Frankel J., Conti J.: Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer, 73: 273-280, 1994.
32. Moertel C.G., Childs D.S.Jr., Reitemeier R.J., Colby M.Y.Jr., Holbrook M.A.: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet, 2: 865-867, 1969.
33. Mohiuddin M., Ahmad N.R.: Pre-operative chemoradiation for advanced rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 25: 923-924, 1993.
34. Mohiuddin M., Marks G.: Adjuvant radiation therapy for colon and rectal cancer. Semin. Oncol., 18: 411-420, 1991.
35. Ng A.K., Recht A., Busse P.M.: Sphincter preservation therapy for distal rectal carcinoma. A review. Cancer, 79: 671-683, 1997.
36. Nicholls R.J., Hall C.: Treatment of non-disseminated cancer of the lower rectum. Br. J. Surg., 83: 15-18, 1996.
37. NIH consensus conference. Adjuvant therapy for patients ' with colon and rectal cancer. JAMA, 264: 1444-1450, 1990.
38. O'Connell M.J., Martenson J.A., Wieand H.S.: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N. Engl. J. Med., 331: 502-507, 1994.
39. Pahlman L., Glimelius B.: Pre-operative and post-operative radiotherapy and rectal cancer. World. J. Surg., 16: 858-865, 1992.
40. Pahlman L., Glimelius B.: Preoperative Radiotherapy is better than postoperative radiotherapy in patients with rectal cancer. Gastroenterology, 99: 895-897, 1990.
41. Proceeding Innovative Options in Rectal Cancer Mangement. An International Consensus Type Meeting. Ciné-Med, Philadelphia 1997.
42. Randomized study on preoperative radiotherapy in rectal carcinoma. Stockholm Colorectal Cancer Study Group [see comments]. Ann. Surg. Oncol., 3: 423-430, 1996.
43. Randomized trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party. Lancet, 348: 1605-1610, 1996.
44. Randomized trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal Cancer Working Party. Lancet, 348: 1610-1614, 1996.
45. Reis Neto J., Quilici F., Reis A.: Preoperative radiotherapy in rectal carcinoma. Disease colon & rectum, 32: 702-710, 1989.
46. Rich T.A., Skibber J.M., Ajani J.A., Buchholz D.J., Cleary K.R., DuBrow R.A., Levin B., Lynch P.M., Materissian S.H., Roubein L.D., Ota D.M.: Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 32: 1025-1029, 1995.
47. Rider W.D., Palmer J.A., Mahoney L.J., Robertson C.T.: Preoperative irradiation in operable cancer of the rectum: report of the Toronto trial. Can. J. Surg., 20: 335-338, 1977.
48. Rosenthal C.J., Rotman M.: The development of chemotherapy drugs as radiosensitizers: an overview. In: Concomitant Continous Infusion Chemotherapy and Radiation, Rotman M., Rosenthal C.J. (eds.), pp. 1-9, Springer Verlag, Berlin, 1991.
49. Stearns M.W.Jr., Deddish M.R., Quan S.H., Leaming R.H.: Preoperative roentgen therapy for cancer of the rectum and rectosigmoid. Surg. Gynecol. Obstet., 138: 584-586, 1974.
50. Stearns M.W.Jr., Deddish M.R., Quan S.H.Q.: Preoperative roentgen therapy for cancer of the rectum. Surg. Gynecol. Obstet., 109: 225-229, 1959.
51. Swedish rectal cancer Trial., Pahlman L.: Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Br. J. Surg., 80: 1333-1336, 1993.
52. Taat C.: in Proceeding Innovative Options in Rectal Cancer Mangement. An International Consensus Type Meeting. Ciné-Med, Philadelphia 1997.
53. Tepper J.E., O'Connell M.J., Petroni G.R., Hollis D., Cooke E., Benson A.B., Cummings B., Gunderson L.L., Macdonald J.S., Martenson J.A.: Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. J. Clin. Oncol., 15: 2030-2039, 1997.
54. Tepper J.E.: Adjuvant irradiation of gastrointestinal malignancies: impact on local control and tumor cure. Int. J. Radiat. Oncol. Biol. Phys., 12: 667-671, 1986.
55. Tepper J.E.: Reflections in rectosigmoid: retro-peritoneal vs. intra- peritoneal. Int. J. Radiat. Oncol. Biol. Phys., 14: 1043-1046, 1988.
56. Treurniet Donker A.D., van Putten W.L., Wereldsma J.C.: Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The Netherlands. Cancer, 67: 2028-2042, 1991.
57. UICC International Union Against Cancer TNM Classification of Malignant Tumours, pp. 3-19, Springer Verlag, Geneva, 1997.
58. Valentini V., Coco C., Cellini N., Picciocchi A., Genovesi D., Mantini G., Barbaro B., Cogliandolo S., Mattana C., Tedesco M., Ambesi-Impiombato F., Cosimelli M.: Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Int. J. Radiat. Oncol. Biol. Phys., 40, 5, in press, 1998.
59. Valentini V., Morganti A.G., Luzi S., Mantello G., Mantini G., Salvi G., Cellini N.: Cancer is chemoradiation feasible in elderly patients ? A study on 17 patients with analrectal cancer. Cancer, 73: 273-280, 1997.
60. Valentini V., Luzi S., Mantini G., Turriziani A., Cellini N.: Concomitant radiochemo-therapy in rectal cancer: methodology and indications. Rays, 20: 90-111, 1995.
61. Vokes E.E., Weichselbaum R.R.: Concomitant chemoradiotherapy rationale and clinical experience in patients with solid tumors. J. Clin. Oncol., 8: 911-934, 1990.
62. Wang C.C., Schulz M.D.: The role of radiation therapy in the management of carcinoma of the sigmoid, rectosigmoid, and rectum. Radiology, 79: 1-5, 1962.